loading

Corvus Pharmaceuticals Inc Azioni (CRVS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
10.65%
6.253
5.651 5.56 5.622 6.574
Depreciation and Amortization
70.13%
0.023
0.077 0.03 0.036 0.057
Operating Income/Loss
10.65%
-6.253
-5.651 -5.56 -5.622 -6.574
Income/Loss Before Equity Method Investments
-5.937
- - - -
Income/Loss From Continuing Operations Before Tax
10.76%
-5.937
-6.653 -6.00 -6.503 -7.873
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
10.76%
-5.937
-6.653 -6.00 -6.503 -7.873
Net Income/Loss
14.31%
-5.701
-6.653 -6.00 -6.503 -7.873
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
14,261%
49.04
0.3415 48.97 47.50 46.56
Diluted Average Shares
14,261%
49.04
0.3415 48.97 47.50 46.56
Basic Earnings Per Share
7.69%
-0.12
-0.13 -0.12 -0.14 -0.17
Diluted Earnings Per Share
7.69%
-0.12
-0.13 -0.12 -0.14 -0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Capitalizzazione:     |  Volume (24 ore):